These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31545497)

  • 1. Evaluation of cytochrome P450 3A4‑mediated drug‑drug interaction potential between P2Y12 inhibitors and statins.
    Zhang B; Zhan G; Fang Q; Wang F; Li Y; Zhang Y; Zhao L; Zhang G; Li B
    Mol Med Rep; 2019 Nov; 20(5):4713-4722. PubMed ID: 31545497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic In Vitro Studies Indicate that the Clinical Drug-Drug Interaction between Telithromycin and Simvastatin Acid Is Driven by Time-Dependent Inhibition of CYP3A4 with Minimal Effect on OATP1B1.
    Elsby R; Hare V; Neal H; Outteridge S; Pearson C; Plant K; Gill RU; Butler P; Riley RJ
    Drug Metab Dispos; 2019 Jan; 47(1):1-8. PubMed ID: 30348903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration.
    Gupta A; Harris JJ; Lin J; Bulgarelli JP; Birmingham BK; Grimm SW
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5986-94. PubMed ID: 27458210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enhancement of cardiotoxicity that results from inhibiton of CYP 3A4 activity and hERG channel by berberine in combination with statins.
    Feng P; Zhao L; Guo F; Zhang B; Fang L; Zhan G; Xu X; Fang Q; Liang Z; Li B
    Chem Biol Interact; 2018 Sep; 293():115-123. PubMed ID: 30086269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitors.
    Lee CK; Choi JS; Choi DH
    Pharmacol Rep; 2015 Feb; 67(1):44-51. PubMed ID: 25560574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of P2Y12 Receptor Blockers After Myocardial Infarction and Genetic Variability of their Metabolic Pathways.
    Máchal J; Hlinomaz O
    Curr Vasc Pharmacol; 2019; 17(1):35-40. PubMed ID: 29412111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors.
    Yang SH; Choi JS; Choi DH
    Pharmacology; 2011; 88(1-2):1-9. PubMed ID: 21709429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the ticagrelor-statin interplay in the PLATO trial.
    Dinicolantonio JJ; Serebruany VL
    Cardiology; 2013; 124(2):105-7. PubMed ID: 23407140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.
    Williams D; Feely J
    Clin Pharmacokinet; 2002; 41(5):343-70. PubMed ID: 12036392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
    Jacobson TA
    Am J Cardiol; 2004 Nov; 94(9):1140-6. PubMed ID: 15518608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population.
    Bakhai A; Rigney U; Hollis S; Emmas C
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):485-93. PubMed ID: 22237927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baicalein inhibits the pharmacokinetics of simvastatin in rats
    Meng M; Li X; Zhang X; Sun B
    Pharm Biol; 2021 Dec; 59(1):880-883. PubMed ID: 34214011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex difference in inhibition of in vitro mexazolam metabolism by various 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors in rat liver microsomes.
    Ishigami M; Takasaki W; Ikeda T; Komai T; Ito K; Sugiyama Y
    Drug Metab Dispos; 2002 Aug; 30(8):904-10. PubMed ID: 12124308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymes.
    Cohen LH; van Leeuwen RE; van Thiel GC; van Pelt JF; Yap SH
    Biopharm Drug Dispos; 2000 Dec; 21(9):353-64. PubMed ID: 11523064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration with simvastatin or lovastatin alters the pharmacokinetic profile of sinomenine in rats through cytochrome P450-mediated pathways.
    Wang Y; Jin Y; Yun X; Wang M; Dai Y; Xia Y
    Life Sci; 2018 Sep; 209():228-235. PubMed ID: 30096386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance.
    Neuvonen PJ; Niemi M; Backman JT
    Clin Pharmacol Ther; 2006 Dec; 80(6):565-81. PubMed ID: 17178259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine.
    Birnbaum Y; Birnbaum GD; Birnbaum I; Nylander S; Ye Y
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):539-550. PubMed ID: 27830382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of 3-hydroxy-3-methylglutaryl-coenzyme a (HMG-CoA) reductase inhibitors on the CYP3A4-dependent oxidation of mexazolam in vitro.
    Ishigami M; Honda T; Takasaki W; Ikeda T; Komai T; Ito K; Sugiyama Y
    Drug Metab Dispos; 2001 Mar; 29(3):282-8. PubMed ID: 11181496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of resveratrol on the pharmacokinetics of ticagrelor in vivo and in vitro.
    Wang P; Hu XX; Li YH; Gao NY; Chen GQ; Chen JL
    Can J Physiol Pharmacol; 2021 Aug; 99(8):821-826. PubMed ID: 33400617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-medication of statins and CYP3A4 inhibitors before and after introduction of new reimbursement policy.
    Devold HM; Molden E; Skurtveit S; Furu K
    Br J Clin Pharmacol; 2009 Feb; 67(2):234-41. PubMed ID: 19220274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.